AOD-9604: Research on Metabolic Peptides
Understanding This Modified Fragment of Human Growth Hormone
Short answer: AOD-9604 is a modified fragment of human growth hormone (amino acids 176–191 plus a tyrosine). It is studied in metabolic research.
Last updated: 20 October 2026
Introduction
AOD-9604 (Anti-Obesity Drug 9604) is a modified fragment of human growth hormone (hGH) that researchers study for its potential role in metabolic processes. Unlike full-length growth hormone, AOD-9604 is a small peptide fragment considered to focus on specific metabolic pathways without broader hormonal effects.
What Is AOD-9604?
AOD-9604 is a modified form of the C-terminal fragment of hGH, consisting of amino acids 176-191. The modification involves adding a tyrosine residue to the N-terminus.
Key properties:
- 16 amino acids (modified hGH 176-191)
- Molecular weight: ~1815 g/mol
- Studied for lipolysis and fat metabolism
- Considered to lack broader GH effects
Applications de recherche
- Fat metabolism studies — Potential lipolytic effects
- Metabolic research — Glucose and lipid metabolism
- Weight management research — Appetite and energy expenditure signaling
Conclusion
AOD-9604 offers researchers a targeted tool for studying metabolic pathways without the broader effects associated with full growth hormone.
Questions fréquentes
What is AOD-9604 derived from?
The C-terminal fragment of human growth hormone, amino acids 176–191.
How is it modified?
A tyrosine residue is added to the N-terminus.
What is it studied for?
Metabolic research, as a fragment considered to focus on specific metabolic pathways without broader hormonal effects.
Related: Lab reports (COA)